Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PACIRA BIOSCIENCES, INC.

(PCRX)
  Report
Real-time Estimate Cboe BZX  -  01:44 2022-11-28 pm EST
49.25 USD   -0.89%
11/15Sector Update: Health Care Stocks Edge Higher Premarket Tuesday
MT
11/15Pacira BioSciences Reports Higher Exparel Preliminary Net Product Sales in October; Wedbush Maintains Forecast
MT
11/14Pacira BioSciences Reports Higher Exparel Preliminary Net Product Sales in October
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Days
:
Hours
:
Minutes
:
Seconds
Most relevant news about PACIRA BIOSCIENCES, INC.
11/15Pacira BioSciences Reports Higher Exparel Preliminary Net Product Sales in October; Wed..
MT
11/14Pacira BioSciences Reports Higher Exparel Preliminary Net Product Sales in October
MT
11/14Pacira BioSciences Reports Preliminary Net Product Sales of $54.9 Million for October 2..
GL
11/14Pacira BioSciences Reports Preliminary Net Product Sales of $54.9 Million for October 2..
GL
11/08Pacira BioSciences to Present at Two Healthcare Conferences in November
GL
11/07BMO Capital Adjusts Price Target on Pacira BioSciences to $60 From $66, Maintains Marke..
MT
11/04HC Wainwright Adjusts Price Target on Pacira BioSciences to $76 From $83, Maintains Buy..
MT
11/04RBC Trims Pacira BioSciences' Price Target to $80 From $82, Keeps Outperform Rating
MT
11/04Wedbush Lowers Pacira BioSciences' Price Target to $88 From $94, Keeps Outperform Ratin..
MT
11/03Pacira BioSciences Q3 Non-GAAP Net Income Declines, Revenue Rises -- Shares Fall
MT
11/03Transcript : Pacira BioSciences, Inc., Q3 2022 Earnings Call, Nov 03, 2022
CI
11/03Pacira : Q3 Earnings Snapshot
AQ
11/03Pacira BioSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months..
CI
11/03Pacira BioSciences Reports Third Quarter 2022 Financial Results
GL
11/03Pacira BioSciences Reports Third Quarter 2022 Financial Results
AQ
More most relevant news
All news about PACIRA BIOSCIENCES, INC.
11/15Sector Update: Health Care Stocks Edge Higher Premarket Tuesday
MT
11/15Pacira BioSciences Reports Higher Exparel Preliminary Net Product Sales in October; Wed..
MT
11/14Pacira BioSciences Reports Higher Exparel Preliminary Net Product Sales in October
MT
11/14Pacira BioSciences Reports Preliminary Net Product Sales of $54.9 Million for October 2..
GL
11/14Pacira BioSciences Reports Preliminary Net Product Sales of $54.9 Million for October 2..
GL
11/08Pacira BioSciences to Present at Two Healthcare Conferences in November
GL
11/07BMO Capital Adjusts Price Target on Pacira BioSciences to $60 From $66, Maintains Marke..
MT
11/04HC Wainwright Adjusts Price Target on Pacira BioSciences to $76 From $83, Maintains Buy..
MT
11/04RBC Trims Pacira BioSciences' Price Target to $80 From $82, Keeps Outperform Rating
MT
11/04Wedbush Lowers Pacira BioSciences' Price Target to $88 From $94, Keeps Outperform Ratin..
MT
More news
News in other languages on PACIRA BIOSCIENCES, INC.
11/15Mise à jour sectorielle : Les actions du secteur de la santé son..
11/14Pacira BioSciences annonce une hausse des ventes nettes de produits préliminaires Expar..
11/03Le bénéfice net non conforme aux PCGR de Pacira BioSciences au 3e trimestre diminue, le..
11/03Pacira BioSciences, Inc. annonce ses résultats pour le troisième trimestre et les neuf ..
10/13Pacira BioScience annonce des revenus préliminaires de 167,5 millions de dollars pour l..
09/27Pacira BioSciences et Sevaredent concluent un partenariat sur l'accès élargi à Exparel ..
09/27Sevaredent Sourcing Solutions et Pacira BioSciences, Inc. collaborent pour fournir un a..
09/21Pacira Biosciences annonce les premiers résultats positifs de l'étude de phase 3 sur Ex..
09/20Pacira BioSciences reçoit un avis positif pour le traitement de la douleur post-chirurg..
09/20Pacira BioSciences, Inc. reçoit un avis positif du CHMP pour Exparel« dans le traitemen..
More news
Analyst Recommendations on PACIRA BIOSCIENCES, INC.
11/07BMO Capital Adjusts Price Target on Pacira BioSciences to $60 From $66, Maintains Marke..
MT
11/04HC Wainwright Adjusts Price Target on Pacira BioSciences to $76 From $83, Maintains Buy..
MT
11/04RBC Trims Pacira BioSciences' Price Target to $80 From $82, Keeps Outperform Rating
MT
11/04Wedbush Lowers Pacira BioSciences' Price Target to $88 From $94, Keeps Outperform Ratin..
MT
10/21Jefferies Assumes Pacira BioSciences at Buy with $66 Price Target
MT
More recommendations
Press releases
11/14Pacira BioSciences Reports Preliminary Net Product Sales of $54.9 Million for October 2..
GL
11/14Pacira BioSciences Reports Preliminary Net Product Sales of $54.9 Million for October 2..
GL
11/08Pacira BioSciences to Present at Two Healthcare Conferences in November
GL
11/03PACIRA BIOSCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
AQ
11/03Pacira : Q3 Earnings Snapshot
AQ
More press releases
Upcoming event on PACIRA BIOSCIENCES, INC.